A study led by pioneering Lankenau Institute for Medical Research scientist Ellen Heber-Katz, PhD, has demonstrated the ability of an experimental regenerative medicine developed in her lab to restore bone in an animal.
Tag: Bone Disease
Mount Sinai Researchers Develop a First-in-Class Humanized Antibody Targeting Bone and Fat
Blocking the Follicle-Stimulating Hormone (FSH) whose levels rise at menopause could solve bone loss and weight gain Senior Author: Mone Zaidi, MD, PhD, MACP, Director of the Mount Sinai Bone Program and Professor of Medicine (Endocrinology, Diabetes and Bone Disease) at…
IU cancer researcher earns $1.6 million NCI grant for multiple myeloma bone disease therapies
David Roodman is leading research to investigate a molecule that could repair bone, decrease tumors and improve outcomes for multiple myeloma patients on specific targeted therapies.